Welles Robinson
发表
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.
Mark D. M. Leiserson,
R. Sharan,
D. Hochbaum,
2020,
Genome Medicine.
Mark D. M. Leiserson,
R. Sharan,
T. Przytycka,
2020,
iScience.
E. Ruppin,
S. Hannenhalli,
J. Leor,
2018,
Scientific Reports.
J. Gartner,
S. Sindiri,
S. Rosenberg,
2022,
Clinical cancer research : an official journal of the American Association for Cancer Research.
Mark D. M. Leiserson,
A. Schäffer,
E. Ruppin,
2020,
bioRxiv.
E. Ruppin,
S. Hannenhalli,
J. Leor,
2018,
Scientific Reports.
Roded Sharan,
Mark D. M. Leiserson,
Welles Robinson,
2019,
Bioinform..
Roded Sharan,
Teresa M. Przytycka,
Mark D. M. Leiserson,
2019,
RECOMB.
Roded Sharan,
Dorit S. Hochbaum,
Teresa M. Przytycka,
2019,
Genome Medicine.
A. Regev,
E. Ruppin,
S. Wiemann,
2022,
Cancer discovery.
A. Schäffer,
E. Ruppin,
E. Gertz,
2021,
bioRxiv.
Erfan Sadeqi Azer,
A. Buluç,
S. C. Sahinalp,
2021,
bioRxiv.
E. Ruppin,
P. Meltzer,
C. Benes,
2018,
Nature Communications.
Mark D. M. Leiserson,
A. Schäffer,
E. Ruppin,
2021
.
Characterization of HLH-Like Manifestations as a CRS Variant in Patients Receiving CD22 CAR T-Cells.
E. Ruppin,
S. Steinberg,
N. Taylor,
2021,
Blood.
Mark D. M. Leiserson,
A. Schäffer,
E. Ruppin,
2023,
bioRxiv.
Alejandro A. Schäffer,
Yuzhen Ye,
Kaiyuan Zhu,
2020,
bioRxiv.
Eytan Ruppin,
Sridhar Hannenhalli,
Paul S. Meltzer,
2018,
Nature Communications.
A. Schäffer,
E. Ruppin,
E. Gertz,
2020
.
Mark D. M. Leiserson,
E. Gertz,
E. Ruppin,
2024,
Science advances.
Adam A. Friedman,
E. Ruppin,
K. Flaherty,
2018,
bioRxiv.
E. Ruppin,
E. Gertz,
T. Greten,
2023,
Cell.